Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

Factor V Leiden and the Risk of Bleeding in Patients With Acute Coronary Syndromes Treated With Antiplatelet Therapy: Pooled Analysis of 3 Randomized Clinical Trials

Background Whether factor V Leiden is associated with lower bleeding risk in patients with acute coronary syndromes using (dual) antiplatelet therapy has yet to be investigated. Methods and Results We pooled data from 3 randomized clinical trials, conducted in patients with acute coronary syndromes,...

Full description

Bibliographic Details
Main Authors: Bakhtawar K. Mahmoodi, Niclas Eriksson, Stephanie Ross, Daniel M. F. Claassens, Folkert W. Asselbergs, Karina Meijer, Agneta Siegbahn, Stefan James, Guillaume Pare, Lars Wallentin, Jurriën M. ten Berg
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
acute coronary syndrome
antiplatelet therapy
bleeding
factor V Leiden
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.021115

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.120.021115

Similar Items